22157.jpg
Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2023: Over 65 Companies Developing Drugs for COPD with Several in Phase III of Testing
05 avr. 2023 04h33 HE | Research and Markets
Dublin, April 05, 2023 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This report...